Here are the S-1 registration statements from Healthlynked Corp New (HLYKD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow HLYKD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HLYKD filings page.
HealthLynked Corp. is planning a $7,000,000 public offering of up to 1,750,000 shares of common stock, plus 150,000 shares registered for resale by a selling stockholder. The company expects an offering price between $4.00 and $6.00 per share and has applied to list on Nasdaq under the symbol HLYK; the deal will not close if listing is not approved.
At an assumed $5.00 price for 1,400,000 shares, net proceeds are estimated at about $6.16 million, or $7.14 million if the underwriter’s over-allotment is fully exercised. As of March 31, 2026, HealthLynked held cash of $23,973, with a working capital deficit of $6,658,253 and an accumulated deficit of $52,196,869, leading auditors to raise substantial doubt about its ability to continue as a going concern absent this financing and other capital raises.
HealthLynked Corp. is registering $7,000,000 of common stock in a public offering and 150,000 additional shares for resale by a selling stockholder. The primary sale is expected to price between $4.00 and $6.00 per share, with an assumed 1,400,000 shares at $5.00 for illustrative purposes.
The company estimates net proceeds of about $6.16 million (or $7.14 million with full over-allotment), to fund working capital, capital expenditures, research and development, sales and marketing, and repayment of specific debts. A significant portion of related-party convertible debt held by CEO Dr. Michael Dent is assumed to convert into equity for Nasdaq listing purposes.
HealthLynked reports cash of $37,136, a working capital deficit of $5.46 million and an accumulated deficit of $50.54 million as of December 31, 2025, leading to substantial doubt about its ability to continue as a going concern. Management believes proceeds from this offering, if completed, will help address liquidity concerns for at least the next twelve months.